REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,310,822 | -19.1% | 4,037,561 | +78.5% | 0.02% | -11.1% |
| Q2 2023 | $57,263,344 | -21.8% | 2,262,479 | -0.5% | 0.03% | -27.0% |
| Q1 2023 | $73,261,357 | +66.4% | 2,274,491 | -4.6% | 0.04% | +60.9% |
| Q4 2022 | $44,019,531 | -31.7% | 2,384,590 | -0.1% | 0.02% | -34.3% |
| Q3 2022 | $64,422,000 | +97.0% | 2,386,018 | +0.8% | 0.04% | +118.8% |
| Q2 2022 | $32,703,000 | -24.2% | 2,366,367 | +6.9% | 0.02% | -5.9% |
| Q1 2022 | $43,154,000 | +45.3% | 2,213,047 | +21.6% | 0.02% | +54.5% |
| Q4 2021 | $29,704,000 | -41.5% | 1,820,069 | -0.1% | 0.01% | -42.1% |
| Q3 2021 | $50,751,000 | -6.2% | 1,821,679 | -0.2% | 0.02% | -9.5% |
| Q2 2021 | $54,116,000 | +10.2% | 1,825,767 | +3.9% | 0.02% | +5.0% |
| Q1 2021 | $49,098,000 | -1.3% | 1,756,610 | +0.0% | 0.02% | -4.8% |
| Q4 2020 | $49,762,000 | -23.2% | 1,755,863 | -31.9% | 0.02% | -32.3% |
| Q3 2020 | $64,811,000 | -22.2% | 2,578,033 | -25.6% | 0.03% | -27.9% |
| Q2 2020 | $83,309,000 | +52.5% | 3,466,888 | -6.1% | 0.04% | +19.4% |
| Q1 2020 | $54,634,000 | -6.0% | 3,691,488 | +3.0% | 0.04% | +16.1% |
| Q4 2019 | $58,152,000 | +25.4% | 3,582,972 | +0.5% | 0.03% | +24.0% |
| Q3 2019 | $46,366,000 | +1.7% | 3,566,575 | +1.5% | 0.02% | +4.2% |
| Q2 2019 | $45,577,000 | -15.7% | 3,514,050 | +2.5% | 0.02% | -17.2% |
| Q1 2019 | $54,045,000 | -9.8% | 3,429,256 | +15.2% | 0.03% | -19.4% |
| Q4 2018 | $59,904,000 | -5.5% | 2,975,844 | +16.7% | 0.04% | +12.5% |
| Q3 2018 | $63,361,000 | -13.0% | 2,549,735 | -3.9% | 0.03% | -13.5% |
| Q2 2018 | $72,865,000 | -25.4% | 2,654,436 | -16.3% | 0.04% | -26.0% |
| Q1 2018 | $97,733,000 | -19.5% | 3,173,162 | -6.5% | 0.05% | -13.8% |
| Q4 2017 | $121,343,000 | +33.9% | 3,394,202 | +3.2% | 0.06% | +31.8% |
| Q3 2017 | $90,606,000 | +1.7% | 3,288,778 | -2.6% | 0.04% | 0.0% |
| Q2 2017 | $89,106,000 | +43.6% | 3,375,238 | +13.1% | 0.04% | +41.9% |
| Q1 2017 | $62,059,000 | -8.6% | 2,983,600 | -9.1% | 0.03% | -11.4% |
| Q4 2016 | $67,908,000 | +34.8% | 3,280,584 | +5.6% | 0.04% | +34.6% |
| Q3 2016 | $50,369,000 | +17.0% | 3,107,279 | -1.9% | 0.03% | +13.0% |
| Q2 2016 | $43,065,000 | -25.9% | 3,166,536 | -4.9% | 0.02% | -25.8% |
| Q1 2016 | $58,126,000 | -46.5% | 3,329,070 | +4.7% | 0.03% | -43.6% |
| Q4 2015 | $108,591,000 | +12.5% | 3,178,895 | -2.0% | 0.06% | +14.6% |
| Q3 2015 | $96,549,000 | -1.6% | 3,244,280 | +5.8% | 0.05% | +6.7% |
| Q2 2015 | $98,079,000 | +39.2% | 3,066,887 | -9.7% | 0.04% | +40.6% |
| Q1 2015 | $70,444,000 | +51.0% | 3,398,192 | +23.4% | 0.03% | +52.4% |
| Q4 2014 | $46,654,000 | +74.0% | 2,754,139 | +98.6% | 0.02% | +75.0% |
| Q3 2014 | $26,809,000 | +127.4% | 1,386,899 | +300.1% | 0.01% | +140.0% |
| Q2 2014 | $11,787,000 | – | 346,663 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |